t-PA activity in peripheral blood obtained from pregnant women. 1994

A Ishii, and S Yamada, and R Yamada, and H Hamada
Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Kawasaki, Japan.

Concentrations of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) were measured in blood obtained from pregnant women to elucidate the fluctuations in the fibrinolytic system which occur during the course of pregnancy. The t-PA activity was measured with a modified bioimmunoassay using anti-t-PA monoclonal antibody (SP-322) against a single chain of recombinant t-PA. The t-PA antigen was measured by ELISA using the same antibody. PAI activity was determined with a competitive inhibition assay of t-PA activity. In early pregnancy, t-PA activity was found to be close to the standard range seen in nonpregnant women, and gradually decreased during the course of pregnancy, then recovered to rise to the normal range within 48 hours after delivery. The t-PA antigen and PAI activity levels rose slowly during the course of pregnancy, and fell promptly after delivery. t-PA activity and t-PA antigen in levels in umbilical cord blood were higher after vaginal delivery than after cesarean section. These findings suggest that there may be an important physiological balance of the fibrinolytic system between mother and fetus during the course of pregnancy and the puerperium.

UI MeSH Term Description Entries
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017395 Plasminogen Activator Inhibitor 1 A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators. PAI-1,SERPINE1 Protein,Serpin E1,Type 1 Plasminogen Activator Inhibitor,E1, Serpin,Protein, SERPINE1
D049590 Postpartum Period In females, the period that is shortly after giving birth (PARTURITION). Puerperium,Postpartum,Postpartum Women,Period, Postpartum,Women, Postpartum

Related Publications

A Ishii, and S Yamada, and R Yamada, and H Hamada
October 1984, Lancet (London, England),
A Ishii, and S Yamada, and R Yamada, and H Hamada
July 1971, Ginekologia polska,
A Ishii, and S Yamada, and R Yamada, and H Hamada
January 1972, The Journal of obstetrics and gynaecology of the British Commonwealth,
A Ishii, and S Yamada, and R Yamada, and H Hamada
October 1997, Journal of reproductive immunology,
A Ishii, and S Yamada, and R Yamada, and H Hamada
January 1958, Polskie Archiwum Medycyny Wewnetrznej,
A Ishii, and S Yamada, and R Yamada, and H Hamada
May 2022, Clinical and translational medicine,
A Ishii, and S Yamada, and R Yamada, and H Hamada
March 2004, Infection and immunity,
A Ishii, and S Yamada, and R Yamada, and H Hamada
July 1990, Lancet (London, England),
A Ishii, and S Yamada, and R Yamada, and H Hamada
October 1982, Nihon Sanka Fujinka Gakkai zasshi,
A Ishii, and S Yamada, and R Yamada, and H Hamada
February 2013, Bulletin of experimental biology and medicine,
Copied contents to your clipboard!